Your session is about to expire
← Back to Search
Diagnostic Test
Diagnostic Ultrasound for Patellofemoral Pain Syndrome (POCUS Trial)
N/A
Recruiting
Led By Morgan C Bagley, PhD
Research Sponsored by Youngstown State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will test how well ultrasound can help diagnose patellar tendon injuries.
Who is the study for?
This trial is for female student-athletes aged 18 to 25 who are involved in sports with a lot of jumping. It's designed to help those experiencing knee pain, specifically around the kneecap.
What is being tested?
The study is testing the use of point-of-care ultrasound (POCUS) as an effective tool for diagnosing patellar tendon issues in athletes with knee pain.
What are the potential side effects?
Since POCUS is a diagnostic procedure involving imaging with ultrasound, it does not have side effects like medications or surgeries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes of patellar tendons in jumping athletes
KOOS
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: JumpingExperimental Treatment1 Intervention
Female jumping collegiate athletes
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
POCUS
2016
N/A
~210
Find a Location
Who is running the clinical trial?
Youngstown State UniversityLead Sponsor
26 Previous Clinical Trials
1,964 Total Patients Enrolled
Morgan C Bagley, PhDPrincipal InvestigatorFaculty
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not an 18-25 year old female student-athlete in jump-centric sports.I am a female student-athlete, aged 18-25, involved in sports that require jumping.
Research Study Groups:
This trial has the following groups:- Group 1: Jumping
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.